Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share
Tweet Send to a Friend
Stemline Therapeutics (Nasdaq: STML) announced the pricing of its previously announced underwritten public offering of 3,800,000 shares of its common ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
